Search

everythinglearnresearchcommunity

for

Search:↓

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

Dupilumab may help hair regrowth in some patients with severe atopic dermatitis, but results vary.

New research has found 14 genes linked to the risk of developing alopecia areata, improving understanding and treatment options.

Patients with Discoid Lupus Erythematosus have lower vitamin D and antioxidant levels and higher oxidative stress.

Mice without the vitamin D receptor have bone issues and other health problems, suggesting vitamin D is important for preventing various diseases in humans.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

New understanding of the causes of primary cicatricial alopecia has led to better diagnosis and potential new treatments.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

People with alopecia areata often have higher rates of allergies and autoimmune diseases.

Early diagnosis and aggressive treatment are crucial for Cicatricial Alopecia, and treatment effectiveness varies among patients.

The patient with both scarring and non-scarring hair loss showed complex immune reactions and improved with steroid treatment.

Hair regrowth was seen in 83% of children with alopecia, immune system plays a role in the condition, and various treatments showed effectiveness for hair and nail disorders.

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.

Low-Level Laser Therapy can stimulate healing and cell function, potentially leading to wider medical use.

Targeting Vδ1+T-cells may help treat alopecia areata.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

The document concludes that understanding and treatments for alopecia areata have significantly advanced, now recognizing it as an autoimmune disorder.

Th22 cells are essential for Tβ15-induced hair growth in mice.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Dupilumab helped a 4-year-old grow hair back after another treatment failed.

The document concludes that the skin is a complex organ providing protection, sensation, and healing, with challenges in treating conditions like itchiness.

The skin protects the body, regulates temperature, senses touch, and makes vitamin D.

A woman developed psoriasis after taking certolizumab pegol, improving after stopping the drug and starting other treatments.

Ulcerative colitis can cause skin issues due to immune system problems.

Children with atopic dermatitis often have sleep problems, affecting their growth and behavior.

Both induced and spontaneous AA lymphocytes can cause alopecia areata in mice.